Caisse de Depot et Placement du Quebec (CDPQ)’s Jazz Pharmaceuticals JAZZ Stock Holding History

Caisse de Depot et Placement du Quebec (CDPQ)’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-255,092	Closed	-$37.3M	–	515
2023 Q1	$37.3M	Buy	255,092 +189,341	+288%	+$28M	0.11%	181
2022 Q4	$10.5M	Sell	65,751 -7,848	-11%	-$1.15M	0.03%	321
2022 Q3	$9.81M	Buy	73,599 +46,275	+169%	+$7.04M	0.03%	314
2022 Q2	$4.26M	Buy	27,324 +4,300	+19%	+$662K	0.01%	381
2022 Q1	$3.58M	Buy	+23,024	New	+$3.34M	0.01%	446
2021 Q4	–	Sell	-2,498	Closed	-$325K	–	597
2021 Q3	$325K	Sell	2,498 -35,500	-93%	-$5.36M	﹤0.01%	520
2021 Q2	$6.75M	Buy	37,998 +28,847	+315%	+$5M	0.01%	306
2021 Q1	$1.5M	Sell	9,151 -484	-5%	-$79.6K	﹤0.01%	484
2020 Q4	$1.59M	Buy	9,635 +2,635	+38%	+$392K	﹤0.01%	472
2020 Q3	$998K	Sell	7,000 -5,700	-45%	-$707K	﹤0.01%	540
2020 Q2	$1.4M	Sell	12,700 -1,000	-7%	-$111K	﹤0.01%	469
2020 Q1	$1.37M	Sell	13,700 -58,400	-81%	-$7.55M	﹤0.01%	483
2019 Q4	$10.8M	Buy	72,100 +22,700	+46%	+$3.09M	0.03%	214
2019 Q3	$6.33M	Buy	49,400 +37,900	+330%	+$5.08M	0.02%	304
2019 Q2	$1.64M	Buy	11,500 +600	+6%	+$80.6K	﹤0.01%	539
2019 Q1	$1.56M	Sell	10,900 -500	-4%	-$65.2K	﹤0.01%	536
2018 Q4	$1.41M	Buy	11,400 +500	+5%	+$74.2K	﹤0.01%	544
2018 Q3	$1.83M	Sell	10,900 -400	-4%	-$68.8K	﹤0.01%	531
2018 Q2	$1.95M	Sell	11,300 -700	-6%	-$114K	﹤0.01%	527
2018 Q1	$1.81M	Buy	12,000 +700	+6%	+$103K	﹤0.01%	513
2017 Q4	$1.52M	Sell	11,300 -900	-7%	-$125K	﹤0.01%	556
2017 Q3	$1.79M	Buy	12,200 +200	+2%	+$30.2K	﹤0.01%	515
2017 Q2	$1.86M	Buy	12,000 +1,700	+17%	+$260K	﹤0.01%	494
2017 Q1	$1.5M	Buy	10,300 +800	+8%	+$104K	﹤0.01%	516
2016 Q4	$1.03M	Sell	9,500 -1,400	-13%	-$156K	﹤0.01%	603
2016 Q3	$1.32M	Sell	10,900 -700	-6%	-$94.4K	﹤0.01%	621
2016 Q2	$1.64M	Buy	11,600 +2,000	+21%	+$295K	﹤0.01%	654
2016 Q1	$1.25M	Buy	+9,600	New	+$1.19M	﹤0.01%	683

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Caisse de Depot et Placement du Quebec (CDPQ)'s JAZZ Position: Q2 2023 in Review

Caisse de Depot et Placement du Quebec (CDPQ) sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2023, closing a stake of 255,092 shares — an estimated $37.3M sold.

Caisse de Depot et Placement du Quebec (CDPQ) first reported a position in JAZZ in Q1 2016 and held it in 28 quarters. The position peaked at $37.3M in Q1 2023. 471 funds tracked by Wall St. Rank hold JAZZ as of Q2 2023.

Caisse de Depot et Placement du Quebec (CDPQ) reported no remaining Jazz Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
Caisse de Depot et Placement du Quebec (CDPQ) sold 255,092 Jazz Pharmaceuticals shares in Q2 2023, an estimated $37.3M.
Caisse de Depot et Placement du Quebec (CDPQ) first reported a position in Jazz Pharmaceuticals in Q1 2016 and held it in 28 quarters.
Caisse de Depot et Placement du Quebec (CDPQ)'s Jazz Pharmaceuticals position peaked at $37.3M in Q1 2023.
471 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2023.

Based on Caisse de Depot et Placement du Quebec (CDPQ)'s 13F filing for Q2 2023, filed 14 Aug 2023.